Accuray is a radiation oncology company that develops, manufactures, and sells personalized, innovative treatment solutions. The company’s leading-edge technologies deliver a full range of radiation therapy and radiosurgery treatments, helping patients to live longer, better lives.

The company announced that Heidelberg University Hospital in Germany has treated the world’s first patients with the new TomoEDGE Dynamic Jaws technology combined with VoLO Planning as part of its TomoTherapy System. Heidelberg University Hospital revealed that it successfully treated patients with both prostate and breast cancers.

The TomoEDGE technology permits sharper dose sculpting and reduces treatment time for many patients by roughly half. The result is a precise, yet faster and more customized treatment delivery that is as unique as each patient. The technology also allows those providing the treatment to spare normal tissues while increasing the efficiency of the treatment. The faster treatment time also allows hospitals and clinics to treat more patients per day.

Florian Sterzing, M.D., radiation oncologist with Heidelberg University Hospital, said, “With TomoEDGE we are now able to treat faster the entire spectrum of radiation oncology patients.” For its part, Accuray says it remains committed to providing the most advanced treatments in radiation oncology.

For additional information about Accuray and its technology, visit www.accuray.com

Let us hear your thoughts below: